Haploidentical donor T cells fail to facilitate engraftment but lessen the immune response of host T cells in murine fetal transplantation
In utero transplantation (IUT) of haematopoietic stem cells holds considerable promise as an approach for the management of many congenital haematological and metabolic disorders (Flake et al, 1996; Flake & Zanjani, 1997; Muench & Bárcena, 2004) . It has successfully created long-term, multilineage, allogeneic or even xenogeneic haematopoietic chimaeras in select animal models without the requirement of histocompatibility matching, immunosuppression or myeloablation (Flake et al, 1986; Harrison et al, 1989; Zanjani et al, 1992 Zanjani et al, , 1994 . However, clinical experience with IUT in most circumstances has been unsatisfactory because of limited engraftment. Thus, the future of this approach depends upon developing successful strategies to either improve engraftment in utero or induce donor-specific tolerance allowing for subsequent postnatal therapies.
T lymphocytes present in the marrow inoculum can facilitate engraftment, often at the expense of graft-versus-host disease (GVHD) in postnatal bone marrow transplantation (Kernan et al, 1986; Martin, 1992) as well as in IUT (Bhattacharyya et al, 2002) . Studies have been undertaken to determine which subsets of T cells are beneficial for engraftment and to determine whether these T cells can be separated from those responsible for GVHD. It was reported that donor CD8 + T cells appeared to be responsible for abrogating rejection as well as generating GVHD in postnatal allogeneic bone marrow transplantation (Martin, 1993; Martin et al, 1998) . It was also found that donor CD8 + cells could both induce GVHD and facilitate engraftment in the IUT setting of a totally allogeneic mismatched mouse model (Bhattacharyya et al, 2002) . It was suggested that the graftversus-host effect of donor CD8 + T cells aided stem cell engraftment by generating space in utero, at the cost of potentially severe GVHD. Besides a direct cytotoxic effect on host cells, donor T cells can also produce cytokines, which
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Summary
The effects of donor T cells, or their CD8 + subset, on engraftment and tolerance induction in fetal transplantation were evaluated using an F 1 -intoparent mouse-model that does not permit a graft-versus-host effect. 
Materials and methods

Recipient and donor mice
In utero transplantation
Mice were grouped by different transplant preparations as shown in Table I . All the donor cells were freshly injected within 3 h after preparation. Time-dated pregnant mice (C57BL/6) were subcutaneously anaesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg) on day 13 of gestation. The uterus was exposed through a vertical laparotomy. A 60 lm glass micropipette with bevelled tip was used to inject the transplant inoculum in 5 ll of Roswell Park Memorial Institute (RPMI) 1640 medium. The tip of the micropipette was inserted through the uterine wall into the peritoneal cavity of each fetus to deliver donor cells into the fetuses. Then the abdomen was closed using two layers of 4-O silk suture. After the operation, all mice were housed in an undisturbed room without bedding changes until the pups were 1 week old. Pups were weaned at 3 weeks of age.
Analyses of chimaerism
Peripheral blood was harvested from the tail tip at the age of 1, 2 and 3 months. Recipients were killed between 3 and 5 months of age for obtaining splenocytes, BMC and peritoneal cells. Peritoneal cells were harvested first by flushing the peritoneal cavity with 10 ml PBS/BSA using a syringe with an 18-gauge needle. Subsequently, BMC were harvested by flushing the tibias and femurs with PBS/BSA. At last, spleens were removed under sterile conditions, washed with PBS/BSA untransplanted C57BL/6 mice were processed and stained by the protocols described above as an additional control.
Mixed lymphocyte reaction
T-cell tolerance was evaluated by measuring mixed lymphocyte reaction (MLR) using 5,6-carboxyfluorescein diacetate succinimidyl ester (CFSE) labelling. The responses of CD3 + cells
were quantified by flow cytometry as described (Chen et al, 2003) . Responder cells were red cell-depleted splenocytes from the recipients and stimulator cells were irradiated splenocytes from C57BL/6 (syngeneic), B6D2F 1 (donor strain) and FVB/N (third-party) mice. Splenocytes from untransplanted C57BL/6 mice were used as the control responders. Mixed lymphocyte cultures were harvested after 6 d. The number of recipient daughter T cells generated was recorded and directly compared among the experimental (B6D2F 1 ), third-party (FVB/N) and control (C57BL/6) groups. A relative simulation index (SI) was calculated as follows: SI ¼ (E BDF1 )ME C57BL/6 )/(E FVB/ N )ME C57BL/6 ) where E BDF1 represents the number of events of recipient daughter T cells responsive to B6D2F 1 stimulators; ME C57BL/6 represents the mean number of events of recipient daughter T cells responsive to syngeneic C57BL/6 stimulators, and E FVB/N represents the number of events of recipient daughter T cells responsive to third-party FVB/N stimulators.
Data presentation and statistical methods
The outcomes of the transplants are reported as the range of the results or as the median, to reduce the effects of extremes and outliers. The data are presented as box plots, and show the 10th (lower bar), 25th (box bottom), 50th (median-bar in box), 75th (box top) and 90th (upper bar) percentiles. Circles in the box plots indicate outlying data points between 1AE5 and 3 box lengths from the upper or lower edge of the box. Extremes, shown as an asterisk, were more than 3 box lengths from the upper or lower edge of the box. The chi-square test was used to determine the significance of differences in the survival rates among the transplant groups. The nonparametric Mann-Whitney U-test was used to measure the significance of differences between two transplant groups and the nonparametric Kruskal-Wallis test was used to determine the significance of the effects of a measured parameter among multiple transplant groups. The independent-samples t-test was used to compare proliferation of T cells stimulated by the different stimulator cells. Results were considered significantly different when P < 0AE05.
Results
Graft characteristics and recipient survival
Fetal mice were transplanted with either of three different preparations of donor cells (Table I For each group, 10 pregnant mice were operated upon and a total of 241 fetuses were injected (Table I) . Most newborns were cannibalized by their mothers within the first week after birth. The actual number of live births was not always determined because such a census was believed to agitate the mothers resulting in cannibalization of the newborns. There were no significant differences in survival at 1 month of age among the three groups (P ¼ 0AE764, chi-square test). One mouse in the TDBMC group died by the age of 2 months.
Chimaerism levels in the peripheral blood of recipients
Chimaerism in the peripheral blood was examined at 1, 2 and 3 months of age. Chimaerism levels in the blood were usually less than 0AE2% (Fig 1A) . Nonetheless, the CD8 and LDBMC groups had significantly higher numbers of donor cells in the peripheral blood at 1 month of age than background measurements made using untransplanted mice (P ¼ 0AE007 and 0AE048, respectively). In contrast, there were no significant differences between the TDBMC and untransplanted groups at 1, 2 and 3 months of age (P ‡ 0AE142).
The chimaerism levels of the CD8 and LDBMC groups dropped by 2 months of age, resulting in no significant differences when compared with the untransplanted mice. Two of 12 recipients in the CD8 group still had 0AE10-0AE15% donor cells in the peripheral blood at 3 months of age, allowing for a more detailed analysis of lineage composition. The donor cells consisted of CD8 + T cells, CD19 + B cells and Gr1 + myeloid cells (Fig 2) . The lack of donor CD4 + T cells suggested these cells were derived from mature cells or committed progenitors rather than donor stem cell engraftment. Chimaerism levels in the spleen, bone marrow and peritoneal cavity
Initial engraftment levels were measured in two mice from the CD8 group, 10 d after IUT (at about 3 d of age). There were no detectable donor cells in the peripheral blood, but high levels of donor cells were present in the spleen (0AE79%, both mice) and bone marrow (1AE51% and 0AE65%). CD8 + represented 4AE6-38AE0% of the donor cells detected in the spleen and bone marrow. Moreover, the donor CD8 + cells represented a significant portion of the total number of CD8 + cells detected in the recipients (Fig 3) , indicating that donor T cells can contribute significantly to the neonatal immune system. By 3-5 months of age, the levels of donor cells were below 0AE15% in the spleen and bone marrow. Only the CD8 group showed a significant level of chimaerism in the bone marrow compared with the untransplanted control group (P ¼ 0AE001, Fig 1B) . Two mice from the CD8 group, with the highest levels of donor cells in the peripheral blood, also presented with high levels of donor cells in the bone marrow (0AE10-0AE15%), which were mostly CD8 + cells (Fig 2) and a small number of Gr1 + cells (data not shown). In addition, the engrafted donor cells in the spleen consisted of CD8 + (Fig 2) and CD19 + cells (data not shown).
Despite the low levels of donor cells in the blood, bone marrow and spleen, some recipients in the CD8 and LDBMC groups displayed high levels of donor cells in their peritoneal cavities (Fig 1B) . The median percentage of donor cells in the peritoneal cavities of TDBMC recipients was 0AE05% (range 0-0AE06%), whereas the median percentages of donor cells for the CD8 and LDBMC recipients was fivefold and eightfold higher, respectively. In addition, the persistence of donor CD8 + cells was observed in the peritoneal cavities of two mice with higher peripheral chimaerism in the CD8 group (Fig 2) .
Analysis of T-cell tolerance
To ascertain whether the chimaerism in our recipients was sufficient to induce T-cell tolerance, T cells from the spleens of 3-5-month-old recipients were tested for their proliferative response in mixed lymphocyte cultures. Untransplanted C57BL/6 mice served as controls. A proliferative response to third-party stimulators was observed in all the mice tested. There were five recipients (three in CD8 group, one in LDBMC group and one in TDBMC group) that showed T-cell specific tolerance to donor stimulators. Their T cells were unresponsive to the donor stimulators but responsive to the third-party stimulators when compared with the response to syngeneic stimulators (e.g. Fig 4A; CD8 no. 7; P ¼ 0AE572 and <0AE001, respectively). Seven recipients (two in CD8 group, four in LDBMC group and one in TDBMC group) were found to be hyporesponsive to donor stimulators. Their T-cell responses to donor stimulators was significantly more than to syngeneic stimulators but significantly less than to the third-party stimulators (e.g. Fig 4A; CD8 no. 11; P ¼ 0AE033 and 0AE001, respectively). In three recipients (one in the untransplanted controls and two in TDBMC group), hyper-responsive T cells were observed. The T cells from these mice responded significantly more vigorously to donor stimulators than to the third-party stimulators. The other recipients appeared to be equally responsive to donor and third-party stimulators (e.g. Fig 4A , CD8 no. 10; P ¼ 0AE282).
The relative T-cell responses for the different groups were evaluated by SI (Fig 4B) . The SI differed significantly among the four groups (P ¼ 0AE015, Kruskal-Wallis test). As indicated by the Mann-Whitney U-test, the CD8 and LDBMC groups had significantly lower SI than the untransplanted control group (P ¼ 0AE015 and 0AE003 for the CD8 and LDBMC groups, respectively). The SI of the TDBMC group did not differ significantly from the control group (P ¼ 0AE107). These results indicated that the presence of T cells, including only the CD8 + subset of T cells, in the donor inoculum aided in lessening host T-cell response specific to the donor cells.
A link between tolerance and chimaerism levels was also sought by comparing the levels of chimaerism in the different tissues between tolerant and non-tolerant mice. For these analyses, tolerant animals included those animals that were deemed tolerant or hyporesponsive by the statistical analyses described above. Non-tolerant mice included the remaining animals that had a normal response or were hyper-responsive. There were no significant differences between tolerant and non-tolerant animals in the levels of donor cells in the peripheral blood during the first 3 months of life. Neither was there any significant difference in the frequency of donor cells in the bone marrow at the time of killing. There were, however, a greater number of donor cells in the spleens of tolerant animals (P ¼ 0AE001). Splenic chimaerism in tolerant animals ranged from 0AE00 to 0AE07% (median ¼ 0AE03%), whereas in the non-tolerant animals it ranged from 0AE00 to 0AE05% (median ¼ 0AE00%). The presence of donor cells in the peritoneal cavity was also increased in tolerant mice (P < 0AE001). In the tolerant mice, the peritoneal chimaerism ranged from 0AE04% to 16AE89% with a median of 0AE08%. Donor cells represented 0AE00% to 0AE07% of peritoneal cells, with a median 0AE01%, in non-tolerant mice. Thus, all tolerant mice had at least a small frequency of donor cells in their peritoneal cavity and tended 
Discussion
The observation that T-cell-depleted allografts have a higher rate of graft failure has drawn attention to T cells as facilitators of bone marrow engraftment. The risks and benefits of T cells in IUT are incompletely understood. Clearly, fetal demise because of GVHD will ensue when too many T cells are transplanted (Zanjani et al, 1982; Bhattacharyya et al, 2002) . However, no clear threshold has been established for the dose of T cells that can be tolerated by a human fetus. Moreover, beneficial effects of T cells have been suggested in some studies (Bhattacharyya et al, 2002) . In this study, we used an F 1 -to-parent murine model to elucidate the role of total CD3 + or CD8 + T cells in facilitating tolerance induction and engraftment in the IUT settings so that the role of donor T cells in shaping the development of the immune response could be studied separately from any graft-versus-host effect.
The presence of T cells in grafts resulted in higher shortterm chimaerism but did not support an increase in durable haematopoietic engraftment. Donor CD8 + cells were readily detectable in the spleen and bone marrow of neonatal mice. Donor cells were also detected in the peripheral blood at 1 month of age in mice transplanted with grafts containing T cells. However, by 2 months of age, peripheral blood chimaerism declined to near minimum detection levels in all groups. Some exceptions were observed, such as two recipients in the CD8 group that had 0AE10-0AE15% donor cells in the peripheral blood at 3 months of age. These donor cells did not appear to be the result of stem cell engraftment as only CD8 + ,
CD19
+ and a few Gr1 + cells were detected but no CD4 + donor cells. The lack of donor CD4 + T cells argued against stem cell engraftment. Carrier et al (2000) also observed the persistence of donor CD3 + T cells after IUT. The low levels of durable chimaerism seen in our study are similar to a number of previous reports (Carrier et al, 1995 (Carrier et al, , 1997 Hajdu et al, 1996; Kim et al, 1998; Milner et al, 1999; Oppenheim et al, 2001) . However, high levels of chimaerism have been observed with fully allogeneic IUT in which donor CD8 + T cells could effectively facilitate engraftment (Bhattacharyya et al, 2002) . Likewise, postnatal donor lymphocyte infusion after prenatal tolerance induction has resulted in high levels of engraftment (Hayashi et al, 2002) . As donor T cells did not increase stem cell engraftment in our F 1 -into-parent transplantation model we can conclude that a T-cell mediated graft-versus-host effect is probably responsible for the improved engraftment. Localization of the donor T cells within the haematopoietic tissues, as observed in neonates in this study, positioned these cells to aid haematopoietic engraftment by a cytotoxic mechanism that generates space for donor stem cells. Some mice in this study displayed a surprisingly high level of peritoneal chimaerism at 3-5 months of age. High levels of donor cells in the peritoneum did not necessarily correlate with donor cell levels in the other tissues. Without a consistent presence of donor cells in the other tissues examined, the origin of donor cells in the peritoneum is most likely to be the expansion of donor BMC in situ rather than the egress of mature donor cells from haematopoietic stem cells engrafted in the bone marrow. Thus, an intriguing possibility is that the donor cells in various recipients' tissues might migrate from the peritoneal cavity after their differentiation and maturation. This could explain the presence of Gr1 + myeloid cells observed in mice several months after IUT but without further evidence of stem cell engraftment. Despite low chimaerism levels, T-cell tolerance was observed in some mice, suggesting that marked stem cell engraftment is not necessary for prenatal tolerance induction. The donorspecific MLRs were reduced significantly in the LDBMC and CD8 groups, suggesting a helpful role for donor T cells (total CD3 + or enriched CD8 + cells, respectively) in attenuating the immune response of host T cells to the donors. The levels of donor cells were higher in the peritoneum and spleen of tolerant or hyporesponsive animals, whereas there was no difference in chimaerism levels in the bone marrow. There were also no differences between non-tolerant animals and the tolerant/hyporesponsive mice in the levels of donor cells in the peripheral blood during the first 3 months of life. These findings indicate that tolerance required lasting chimaerism, because all tolerant mice had at least some donor cells in their peritoneum at the time of killing and blood chimaerism measured at the earlier time points did not correlate with tolerance. Several studies have suggested that transplantation with unpurified sources of stem cells might be the best for creating chimaerism and inducing tolerance. One group transplanted a large number of highly purified c-kit + /Lin ) or Sca + /Lin ) cells but failed to induce tolerance in mice despite microchimaerism (Donahue et al, 2001; Sefrioui et al, 2002) . On the contrary, sensitization was observed resulting in the accelerated rejection of skin grafts. This prenatal sensitization, in association with low levels of donor CD3 + cells, was also suggested in this study, as evidenced by two recipients in the TDBMC group that displayed hyper-reactivity of host T cells against donor cells. Additionally, a high dose of highly purified CD90 + CD34 + stem cells (0AE03% CD3 + cells) also failed to induce T-cell tolerance in a human fetus with chronic granulomatous disease . Successful tolerance induction has been reported in mice with minimally purified or unpurified grafts (Carrier et al, 1995; Hajdu et al, 1996; Kim et al, 1998; Hayashi et al, 2002) . Tolerance induction has also been indicated in IUT for human a-thalassaemia with CD34 + stem cells containing 1% CD3 + cells (Hayward et al, 1998) . Taken together, these results raise the possibility that donor T cells might play a role in lessening the immune response of host T cells.
